Cargando…

Effect of Trikafta on bone density, body composition and exercise capacity in CF: A pilot study

BACKGROUND: While the positive effect of Trikafta on cystic fibrosis (CF) pulmonary disease is well established, there is limited data about its effect on bone mineral density (BMD), body composition and exercise capacity. METHODS: A pilot single center study. BMD and body composition were measured...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gur, Michal, Bar–Yoseph, Ronen, Hanna, Moneera, Abboud, Dana, Keidar, Zohar, Palchan, Tala, Toukan, Yazeed, Masarweh, Kamal, Alisha, Irit, Zuckerman‐Levin, Nehama, Bentur, Lea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100338/ https://www.ncbi.nlm.nih.gov/pubmed/36372909 http://dx.doi.org/10.1002/ppul.26243

Ejemplares similares

The Association between IgG and Disease Severity Parameters in CF Patients
por: Gur, Michal, et al.
Publicado: (2021)

The effect of probiotic administration on metabolomics and glucose metabolism in CF patients
por: Gur, Michal, et al.
Publicado: (2022)

Challenges in DICER1-Associated Lung Disease
por: Masarweh, Kamal, et al.
Publicado: (2023)

The Impact of Respiratory Symptoms on the Risk of Serious Bacterial Infection in Febrile Infants < 60 Days Old
por: Masarweh, Kamal, et al.
Publicado: (2023)

Trikafta—Extending Its Success to Less Common Mutations
por: Bentur, Lea, et al.
Publicado: (2022)

Cardiopulmonary Exercise Testing in Childhood in Late Preterms: Comparison to Early Preterms and Term-Born Controls
por: Hochwald, Ori, et al.
Publicado: (2022)

Pregnancy in Cystic Fibrosis—Past, Present, and Future
por: Gur, Michal, et al.
Publicado: (2023)

Individualized Assessment of Exercise Capacity in Response to Acute and Long-Term Enzyme Replacement Therapy in Pediatric Pompe Disease
por: Bar-Yoseph, Ronen, et al.
Publicado: (2021)

Significant exercise limitations after recovery from MIS-C related myocarditis
por: Mainzer, Gur, et al.
Publicado: (2023)

Cleaning and infection control of airway clearance devices used by CF patients
por: Manor, Eynav, et al.
Publicado: (2017)

Novel reaction to new cystic fibrosis medication Trikafta
por: Stashower, Julian, et al.
Publicado: (2021)

Functional Capacity in Patients Who Recovered from Mild COVID-19 with Exertional Dyspnea
por: Dotan, Yaniv, et al.
Publicado: (2022)

Assessment of Airway Bronchodilation by Spirometry Compared to Airway Obstruction in Young Children with Asthma
por: Vilozni, Daphna, et al.
Publicado: (2016)

Moving the Dial on Airway Inflammation in Response to Trikafta in Adolescents with Cystic Fibrosis
por: Lepissier, Agathe, et al.
Publicado: (2023)

Exercise capacity in patients with cystic fibrosis vs. non-cystic fibrosis bronchiectasis
por: Bar-Yoseph, Ronen, et al.
Publicado: (2019)

THE IMPACT OF TRIKAFTA (ELEXACAFTOR/IVACAFTOR/TEZACAFTOR) ON PATIENTS WITH CYSTIC FIBROSIS WITH COVID-19
por: MILES, B., et al.
Publicado: (2022)

Molecular Structures Reveal Synergistic Rescue of Δ508 CFTR by Trikafta Modulators
por: Fiedorczuk, Karol, et al.
Publicado: (2022)

Phenotyping Rare CFTR Mutations Reveal Functional Expression Defects Restored by TRIKAFTA(TM)
por: Laselva, Onofrio, et al.
Publicado: (2021)

Distinctive lipid signatures of bronchial epithelial cells associated with cystic fibrosis drugs, including Trikafta
por: Liessi, Nara, et al.
Publicado: (2020)

A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy
por: Zaher, Anas, et al.
Publicado: (2021)

The cystic fibrosis treatment Trikafta affects the growth, viability, and cell wall of Aspergillus fumigatus biofilms
por: Jones, Jane T., et al.
Publicado: (2023)

Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination
por: Veit, Guido, et al.
Publicado: (2020)

The clinical yield of bronchoscopy in the management of cystic fibrosis: A retrospective multicenter study
por: Gileles‐Hillel, Alex, et al.
Publicado: (2022)

Better understanding of childhood asthma, towards primary prevention – are we there yet? Consideration of pertinent literature
por: Gur, Michal, et al.
Publicado: (2017)

Thoracoscopic surgery for congenital lung lesions—is this the future?
por: Gur, Michal, et al.
Publicado: (2020)

4-week daily airway clearance using oscillating positive-end expiratory pressure versus autogenic drainage in bronchiectasis patients: a randomised controlled trial
por: Livnat, Galit, et al.
Publicado: (2021)

Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma—a suitable treatment option: case report and review of anti-angiogenic treatment options
por: Semenisty, Valeriya, et al.
Publicado: (2015)

Cortisol-Metabolizing Enzymes in Polycystic Ovary Syndrome
por: Blumenfeld, Zeev, et al.
Publicado: (2016)

Effect of Socioeconomic Status and Ethnicity on Glycemic Control in Arab and Jewish Youth with Type 1 Diabetes Mellitus
por: Zuckerman-Levin, Nehama, et al.
Publicado: (2018)

[F18]FDG PET/CT-Derived Metabolic and Volumetric Biomarkers Can Predict Response to Treatment in Locally Advanced Cervical Cancer Patients
por: Gill, Ronit, et al.
Publicado: (2022)

Acute Effects of Insulin on Cardiac Function in Patients with Diabetes Mellitus: Clinical Applicability and Feasibility
por: Daoud Naccache, Deeb, et al.
Publicado: (2020)

A drop in Sahara dust fluxes records the northern limits of the African Humid Period
por: Palchan, Daniel, et al.
Publicado: (2019)

Theoretical insight into OH- and Cl-initiated oxidation of CF(3)OCH(CF(3))(2) and CF(3)OCF(2)CF(2)H & fate of CF(3)OC(X•)(CF(3))(2) and CF(3)OCF(2)CF(2)X• radicals (X=O, O(2))
por: Bai, Feng-Yang, et al.
Publicado: (2017)

Growth, developmental achievements and vaccines timeliness of undocumented migrant children from Eritrea compared with Israelis
por: Mor, Zohar, et al.
Publicado: (2018)

A 26-week, randomized trial of insulin detemir versus NPH insulin in children and adolescents with type 2 diabetes (iDEAt2)
por: Wheeler, Mark D., et al.
Publicado: (2018)

RF26 | PMON335 Once-Weekly Somapacitan Versus Daily Growth Hormone in Children Born Small for Gestational Age: Results From a Randomized Phase 2 Trial
por: Juul, Anders, et al.
Publicado: (2022)

Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis
por: Schäfer, Jürgen, et al.
Publicado: (2018)

OR08-06 Increased Carotid Intima Media Thickness in Pediatric Type 1 Diabetes Is Associated with Disease Duration
por: Cohen, Michal, et al.
Publicado: (2020)

492: CF innate immune defect affects CF intestinal microbiota
por: Scull, C., et al.
Publicado: (2021)

Translation of the quality of life questionnaire for primary ciliary dyskinesia (QOL‐PCD) into Hebrew: The Israeli experience
por: Amirav, Israel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mekgvilamfdemh5s4p00rgibdn